{
  "retracted": false,
  "timestamp": 1464220800000,
  "updates": [
    {
      "timestamp": 1581060222281,
      "identifier": {
        "doi": "10.1038/bjc.2016.133"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/bjc.2016.41"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum: Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer"
}
